O

OrbusNeich Medical Group Holdings Ltd
HKEX:6929

Watchlist Manager
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Watchlist
Price: 4.1 HKD -1.68% Market Closed
Market Cap: 3.4B HKD
Have any thoughts about
OrbusNeich Medical Group Holdings Ltd?
Write Note

Net Margin
OrbusNeich Medical Group Holdings Ltd

25.6%
Current
26%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
25.6%
=
Net Income
38.7m
/
Revenue
151.4m

Net Margin Across Competitors

Country HK
Market Cap 3.4B HKD
Net Margin
26%
Country JP
Market Cap 6.8T JPY
Net Margin
24%
Country CH
Market Cap 37.9B CHF
Net Margin
12%
Country DK
Market Cap 200.9B DKK
Net Margin
19%
Country US
Market Cap 16.9B USD
Net Margin
11%
Country KR
Market Cap 9.9T KRW
Net Margin
-358%
Country CA
Market Cap 6.9B USD
Net Margin
-8%
Country CN
Market Cap 48.6B CNY
Net Margin
42%
Country US
Market Cap 6.3B USD
Net Margin
29%
Country US
Market Cap 6.1B USD
Net Margin
9%
Country UK
Market Cap 4.8B GBP
Net Margin
7%
No Stocks Found

OrbusNeich Medical Group Holdings Ltd
Glance View

Market Cap
3.4B HKD
Industry
Health Care

OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The company employs 880 full-time employees The company went IPO on 2022-12-23. The firm is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The firm's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The firm mainly conducts its businesses in domestic and overseas markets.

Intrinsic Value
4.36 HKD
Undervaluation 6%
Intrinsic Value
Price
O

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
25.6%
=
Net Income
38.7m
/
Revenue
151.4m
What is the Net Margin of OrbusNeich Medical Group Holdings Ltd?

Based on OrbusNeich Medical Group Holdings Ltd's most recent financial statements, the company has Net Margin of 25.6%.